Results
|
1.
|
|
|
2.
|
|
|
3.
|
|
|
4.
|
|
|
5.
|
Amifostine used clinically for salivary gland protection during therapy with radioiodine is cytotoxic for thyroid cancer cells MedStar authors:
- Burman, Kenneth D
- Klubo-Gwiezdzinska, Joanna
- Van Nostrand, Douglas
- Wartofsky, Leonard
Year: 2014
Institution: - MedStar Washington Hospital Center
Department:
- Medicine/Endocrinology
- Medicine/Nuclear Medicine
All authors: - Klubo-Gwiezdzinska J, Costello Jr J, Jensen K, Patel A, Van Nostrand D,Burman KD, Wartofsky L, Vasko V
|
|
6.
|
Effects of dosimetry-guided 131I therapy for metastatic differentiated thyroid cancer on complete blood counts MedStar authors:
- Bikas, A
- Burman, Kenneth D
- Desale, Sameer
- Mete, Mihriye
- Van Nostrand, Douglas
- Wartofsky, Leonard
Year: 2014
Institution:
- MedStar Health Research Institute
- MedStar Heart & Vascular Institute
- MedStar Washington Hospital Center
All authors: - Bikas A, Burman K, Desale S, Mete M, Wartofsky L, Van Nostrand D
|
|
7.
|
Phase II clinical trial of sunitinib as adjunctive treatment in patients with advanced differentiated thyroid cancer MedStar authors:
- Barett, C
- Bikas, A
- Burman, Kenneth D
- Clark, B
- Desale, Sameer
- Kundra, Priya
- Mete, Mihriye
- Wartofsky, Leonard
- Wexler, Jason
- Wray, L
Year: 2014
Institution:
- MedStar Health Research Institute
- MedStar Heart & Vascular Institute
- MedStar Washington Hospital Center
All authors: - Bikas A, Kundra P, Wexler J, Mete M, Desale S, Wray L, Barett C, Clark B, Wartofsky L, Burman K
|
|
8.
|
Survival rate in differentiated thyroid cancer patients with bone metastases. MedStar authors:
- Atkins, Francis
- Burman, Kenneth D
- Khorjekar, Gauri R
- Kulkarni, Kanchan
- Moreau, Shari
- Orquiza, Michael H
- Van Nostrand, Douglas
- Wartofsky, Leonard
Year: 2014
Department:
- Medicine/Endocrinology
- Medicine/General Internal Medicine
- Medicine/Nuclear Medicine
All authors: - Orquiza M, Van Nostrand D, Khorjekar G, Moreau S, Atkins F, Kulkarni K, Burman KD, Wartofsky L
|
|
9.
|
Altered taste after 131I therapy: the frequency, time of onset, severity, and duration MedStar authors:
- Acio, Elmo
- Burman, Kenneth D
- Garcia, Carlos
- Khorjekar, Gauri R
- Kulkarni, Kanchan
- Orquiza, Michael H
- Schneider, M
- Van Nostrand, Douglas
- Wartofsky, Leonard
Year: 2014
Department:
- Medicine/Endocrinology
- Medicine/General Internal Medicine
- Medicine/Nuclear Medicine
All authors: - Orquiza M, Khorjekar G, Schneider M, Kulkarni K, Garcia C, Acio E, Burman K, Wartofsky L,Van Nostrand D
|
|
10.
|
Epiphora and xerophthalmia after 131I therapy: the frequency, time of onset, severity, and duration. MedStar authors:
- Acio, Elmo
- Burman, Kenneth D
- Garcia, Carlos
- Khorjekar, Gauri R
- Kulkarni, Kanchan
- Orquiza, Michael H
- Schneider, M
- Van Nostrand, Douglas
- Wartofsky, Leonard
Year: 2014
Department:
- Medicine/Endocrinology
- Medicine/General Internal Medicine
- Medicine/Nuclear Medicine
All authors: - Orquiza M, Khorjekar G, Schneider M, Kulkarni K, Garcia C, Acio E, Burman K, Wartofsky L, Van Nostrand D
|